Pancreatic tissue protective nature of D-Pinitol studied in streptozotocin-mediated oxidative stress in experimental diabetic rats

European Journal of Pharmacology

Volumn 622, Issue 1-3, 2009, Pages 65-70

  Sivakumar, Selvaraj ^a   Subramanian, Sorimuthu Pillai ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

D Pinitol; Diabetes mellitus; Lipid peroxidation; Oxidative stress; Streptozotocin

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; CERULOPLASMIN; CYCLITOL; DEXTRO PINITOL; FREE RADICAL; GLICLAZIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HYDROPEROXIDE; LIPID; LIPID PEROXIDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; RAT; SOYBEAN; STREPTOZOCIN DIABETES; TISSUE LEVEL; VITAMIN BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; INOSITOL; INSULIN-SECRETING CELLS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PANCREAS; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 70349883922     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.021     Document Type: Article

References (76)

1. Bates S.H., Jones R.B., and Bailey C.J. Insulin-like effect of pinitol. Br. J. Pharmacol. 130 (2000) 1944-1948
2. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
3. Baynes J.W., and Thorpe S.R. The role of oxidative stress in diabetic complications. Curr. Opin. Endocrinol. 3 (1996) 277-284
4. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48 (1999) 1-9
5. Bennett R.A., and Pegg A.E. Alkylation of DNA in rat tissues following administration of streptozotocin. Cancer Res. 41 (1981) 2786-2790
6. Bolzán A.D., and Bianchi M.S. Genotoxicity of streptozotocin. Mutat. Res. 512 (2002) 121-134
7. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 26 (2003) 1589-1596
8. Coskun O., Kanter M., Korkmaz A., and Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol. Res. 51 (2005) 117-123
9. Desai I.D. Vitamin E analysis methods for animal tissues. Methods Enzymol. 105 (1984) 138-147
10. Drabkin D.L., and Austin H.J. Spectrophotometric studies. I. Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J. Biol. Chem. 98 (1932) 719-733
11. El-Demerdash F.M., Yousef M.I., and El-Naga N.I. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol. 43 (2005) 57-63
12. El-Missiry M.A., and El Gindy A.M. Amelioration of alloxan induced diabetes mellitus and oxidative stress in rats by oil of Eruca sativa seeds. Ann. Nutr. Metab. 44 (2000) 97-100
13. Fidan A.F., and Dündar Y. The effects of Yucca schidigera and Quillaja saponaria on DNA damage, protein oxidation, lipid peroxidation, and some biochemical parameters in streptozotocin-induced diabetic rats. J. Diabetes Its Complicat. 22 (2008) 348-356
14. Fonseca V. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus. Curr. Med. Res. Opin. 19 (2003) 635-641
15. Geethan P.K., and Prince P.S. Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic Wistar rats. J. Biochem. Mol. Toxicol. 22 (2008) 220-224
16. Goh S.Y., and Cooper M.E. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 93 (2008) 1143-1152
17. Greenwood M., Kreider R.B., RasMussen C., Almada A.L., and Earnest C.P. D-Pinitol augments whole body creatine retention in man. J. Exer. Physiol. 4 (2001) 41-47
18. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
19. Ham A.J., and Liebler D.C. Vitamin E oxidation in rat liver mitochondria. Biochemistry 34 (1995) 5754-5761
20. Hanley A.J., Williams K., Festa A., Wagenknecht L.E., D'Agostino Jr. R.B., Kempf J., Zinman B., and Haffner S.M. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 53 (2004) 2623-2632
21. Hodgson E.K., and Fridovich I. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. Biochemistry 14 (1975) 5294-5299
22. Hunt J.V., Dean R.T., and Wolff S.P. Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J. 256 (1988) 205-212
23. Jiang Z.Y., Hunt J.V., and Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low-density lipoprotein. Anal. Biochem. 202 (1992) 384-389
24. Jin L., Xue H.Y., Jin L.J., Li S.Y., and Xu Y.P. Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 582 (2008) 162-167
25. Kajimoto Y., and Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann. N. Y. Acad. Sci. 1011 (2004) 168-176
26. Kaneto H., Xu G., Song K.H., Suzuma K., Bonner-Weir S., Sharma A., and Weir G.C. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J. Biol. Chem. 276 (2001) 31099-31104
27. Kehrer J.P. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23 (1993) 21-48
28. Kim J.I., Kim J.C., Kang M.J., Lee M.S., Kim J.J., and Cha I.J. Effects of pinitol isolated from soybeans on glycemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus: a randomized controlled study. Eur. J. Clin. Nutr. 59 (2005) 456-458
29. King J. The transaminases: alanine and aspartate transaminases. In: Van D. (Ed). Practical clinical enzymology (1965), Nostrand Reinhold Co, London 363-395
30. King J. The hydrolases-acid and alkaline phosphatases. In: Van D. (Ed). Practical clinical enzymology (1965), Nostrand Reinhold Co, London 199-208
31. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
32. Kono Y., and Fridovich I. Superoxide radical inhibits catalase. J. Biol. Chem. 257 (1982) 5751-5754
33. Kristal B.S., Koopmans S.J., Jackson C.T., Ikeno Y., Park B.J., and Yu B.P. Oxidant-mediated repression of mitochondrial transcription in diabetic rats. Free Radic. Biol. Med. 22 (1997) 813-822
34. Lenzen S., Drinkgern J., and Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20 (1996) 463-466
35. Liu Z., Li J., Zeng Z., Liu M., and Wang M. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats. Chem. Biol. Interact. 173 (2008) 68-75
36. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
37. Maritim A.C., Sanders R.A., and Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17 (2003) 24-38
38. Matés J.M., and Sánchez-Jiménez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front. Biosci. 4 (1999) D339-D345
39. Meghana K., Sanjeev G., and Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur. J. Pharmacol. 577 (2007) 183-191
40. Misra H.P., and Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247 (1972) 3170-3175
41. Mohan V., Madan Z., Jha R., Deepa R., and Pradeepa R. Diabetes - social and economic perspectives in the new millenium. Int. J. Diab. Dev. Ctries. 24 (2004) 29-35
42. Nayak S.S., and Pattabiraman T.N. A new colorimetric method for the estimation of glycosylated hemoglobin. Clin. Chim. Acta 109 (1981) 267-274
43. Nishigaki I., Hagihara M., Tsunekawa H., Maseki M., and Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem. Med. 25 (1981) 373-378
44. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
45. Numata A., Hokimoto K., Shimada A., Yamaguchi H., and Takaishi K. Plant constituents biologically active to insects. I. Feeding stimulants for the larva of the yellow butterfly Eurema hecabe mandarina. Chem. Pharm. Bull. 27 (1979) 602-608
46. O'Brien B.A., Harmon B.V., Cameron D.P., and Allan D.J. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin models. J. Pathol. 178 (1996) 176-181
47. Obrosova I.G., Van Huysen C., Fathallah L., Cao X.C., Greene D.A., and Stevens M.J. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J. 16 (2002) 123-125
48. Obrosova G.I., Fathallah L., Lul E., and Nourooz-Zadeh J. Early oxidative stress in the diabetic kidney: effect of L-lipoic acid. Free Radic. Biol. Med. 34 (2003) 186-195
49. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
50. Omaye S.T., Turnbull J.D., and Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol. 62 (1979) 3-11
51. Parman T., Wiley M.J., and Wells P.G. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat. Med. 5 (1999) 582-585
52. Phillips D.V., Dougherty D.E., and Smith A.E. Cyclitols in soybean. J. Agric. Food. Chem. 30 (1982) 456-458
53. Raha S., and Robinson B.H. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem. Sci. 25 (2000) 502-508
54. Rakieten N., Rakieten M.L., and Nadkarni M.V. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 29 (1963) 91-98
55. Ravin H.A. An improved colorimetric enzymatic assay of ceruloplasmin. J. Lab. Clin. Med. 5 (1961) 161-168
56. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., and Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588-590
57. Rupérez F.J., García-Martínez D., Baena B., Maeso N., Cifuentes A., Barbas C., and Herrera E. Evolution of oxidative stress parameters and response to oral vitamins E and C in streptozotocin-induced diabetic rats. J. Pharm. Pharmacol. 60 (2008) 871-878
58. Santini S.A., Marra G., Giardina B., Cotroneo P., Mordente A., Martorana G.E., Manto A., and Ghirlanda G. Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46 (1997) 1853-1858
59. Sasaki T., Matsy S., and Sonae A. Effect of acetic acid concentration on the colour reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsh Kagaku 1 (1972) 346-353
60. Sato Y., Hotta N., Sakamoto N., Matsuoka S., Ohishi N., and Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem. Med. 21 (1979) 104-107
61. Schein P.S., Cooney D.A., McMenamin M.G., and Anderson T. Streptozotocin diabetes-further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver. Biochem. Pharmacol. 22 (1973) 2625-2631
62. Sedlak J., and Lindsay R.H. Estimation of total, protein bound and non-protein sulfhydryl groups in tissue with Ellmans reagent. Anal. Biochem. 25 (1968) 293-305
63. Sinclair A.J., Taylor P.B., Lunec J., Girling A.J., and Barnett A.H. Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet. Med. 11 (1994) 893-898
64. Singh R.K., Pandey B.L., Tripathi M., and Pandey V.B. Antiinflammatory effect of (+)-pinitol. Firoterapia 72 (2001) 168-170
65. Sivakumar, S., Subramanian, S., in press. D-Pinitol attenuates the impaired activities of hepatic key enzymes in carbohydrate metabolism of streptozotocin-induced diabetic rats. Gen. Physiol. Biophys.
66. Swidan S.Z., and Montgomery P.A. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus. Pharmacotherapy 18 (1998) 961-972
67. Szkudelski T. The mechanism of alloxan and streptozotocin action in β-cells of the rat pancreas. Physiol. Res. 50 (2001) 537-546
68. Takahara S., Hamilton H.B., Neel J.V., Kobara T.Y., Ogura Y., and Nishimura E.T. Hypocatalasemia: a new genetic carrier state. J. Clin. Invest. 39 (1960) 610-619
69. Tiedge M., Lortz S., Drinkgern J., and Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46 (1997) 1733-1742
70. Torbenson M., Chen Y.Y., Brunt E., Cummings O.W., Gottfried M., Jakate S., Liu Y.C., Yeh M.M., and Ferrell L. Glycogenic hepatopathy: an under recognized hepatic complication of diabetes mellitus. Am. J. Surg. Pathol. 30 (2006) 508-513
71. Vessal M., Hemmati M., and Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 135C (2003) 357-364
72. Vozarova B., Stefan N., Lindsay R.S., Saremi A., Pratley R.E., Bogardus C., and Tataranni P.A. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51 (2002) 1889-1895
73. Whiting P.H., Kalansooriya A., Holbrook I., Haddad F., and Jennings P.E. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br. J. Biomed. Sci. 65 (2008) 71-74
74. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
75. Wolff S.P., and Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem. J. 245 (1987) 243-250
76. Yazdanparast R., Ardestani A., and Jamshidi S. Experimental diabetes treated with Achillea santolina: effect on pancreatic oxidative parameters. J. Ethnopharmacol. 112 (2007) 13-18